Propofol

"Propofol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.

Descriptor ID	D015742
MeSH Number(s)	D02.455.426.559.389.657.773
Concept/Terms	Propofol Propofol 2,6-Diisopropylphenol 2,6 Diisopropylphenol 2,6-Bis(1-methylethyl)phenol Disoprofol Diprivan Diprivan Disoprivan Fresofol Fresofol ICI-35,868 ICI-35,868 ICI 35,868 ICI35,868 ICI-35868 ICI 35868 ICI35868 Ivofol Ivofol Propofol Fresenius Propofol Fresenius Propofol MCT Propofol Rovi Propofol Rovi Propofol-Lipuro Propofol-Lipuro Recofol Recofol Aquafol Aquafol Propofol Abbott Propofol Abbott

Below are MeSH descriptors whose meaning is more general than "Propofol".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Benzene Derivatives [D02.455.426.559.389]
Phenols [D02.455.426.559.389.657]
Propofol [D02.455.426.559.389.657.773]

Below are MeSH descriptors whose meaning is related to "Propofol".

Below are MeSH descriptors whose meaning is more specific than "Propofol".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Propofol" by people in this website by year, and whether "Propofol" was a major or minor topic of these publications.

Bar chart showing 8 publications over 6 distinct years, with a maximum of 3 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
2000	1	0	1
2008	1	0	1
2009	1	0	1
2011	1	0	1
2016	3	0	3

Below are the most recent publications written about "Propofol" by people in Profiles.

Hughes CG, Mailloux PT, Devlin JW, Swan JT, Sanders RD, Anzueto A, Jackson JC, Hoskins AS, Pun BT, Orun OM, Raman R, Stollings JL, Kiehl AL, Duprey MS, Bui LN, O'Neal HR, Snyder A, Gropper MA, Guntupalli KK, Stashenko GJ, Patel MB, Brummel NE, Girard TD, Dittus RS, Bernard GR, Ely EW, Pandharipande PP. Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis. N Engl J Med. 2021 04 15; 384(15):1424-1436.

View in: PubMed
Elvir Lazo OL, White PF, Tang J, Yumul R, Cao X, Yumul F, Hausman J, Hernandez Conte A, Anand KK, Hemaya EG, Zhang X, Wender RH. Propofol versus midazolam for premedication: a placebo-controlled, randomized double-blinded study. Minerva Anestesiol. 2016 11; 82(11):1170-1179.

View in: PubMed
Ishizawa Y, Ahmed OJ, Patel SR, Gale JT, Sierra-Mercado D, Brown EN, Eskandar EN. Dynamics of Propofol-Induced Loss of Consciousness Across Primate Neocortex. J Neurosci. 2016 07 20; 36(29):7718-26.

View in: PubMed
Lampotang S, Lizdas DE, Derendorf H, Gravenstein N, Lok B, Quarles JP. Race-Specific Pharmacodynamic Model of Propofol-Induced Loss of Consciousness. J Clin Pharmacol. 2016 09; 56(9):1141-50.

View in: PubMed
Crespo MJ, Marrero M, Cruz N, Quidgley J, Creagh O, Torres H, Rivera K. Diabetes alters cardiovascular responses to anaesthetic induction agents in STZ-diabetic rats. Diab Vasc Dis Res. 2011 Oct; 8(4):299-302.

View in: PubMed
Senula G, Sacchetti A, Moore S, Cortese T. Impact of addition of propofol to ED formulary. Am J Emerg Med. 2010 Oct; 28(8):880-3.

View in: PubMed
Feliciano CE, de Le?n-Berra R, Hern?ndez-Gait?n MS, Torres HM, Creagh O, Rodr?guez-Mercado R. Provocative test with propofol: experience in patients with cerebral arteriovenous malformations who underwent neuroendovascular procedures. AJNR Am J Neuroradiol. 2010 Mar; 31(3):470-5.

View in: PubMed
Date AA, Nagarsenker MS. Design and evaluation of microemulsions for improved parenteral delivery of propofol. AAPS PharmSciTech. 2008; 9(1):138-45.

View in: PubMed
Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res. 2000 Jan 14; 45(2):360-9.

View in: PubMed
Halestrap AP, Kerr PM, Javadov S, Woodfield KY. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta. 1998 Aug 10; 1366(1-2):79-94.

View in: PubMed

People

Explore

Similar Concepts

Top Journals